Method for treating children in case of chronic viral hepatitis at applying sulfide baths and low-carbonate mineral water

FIELD: medicine, pediatrics.

SUBSTANCE: children should take sulfide baths and for inner intake - warm low-carbonate chloride-hydrocarbonade sodium-calcium water of low mineralization per 100-200 g depending upon patient's age, for 30 d. The innovation provides improved clinical and paraclinical values due to combined intake of sulfide baths, that stimulate nervous centers through vast cutaneous receptor fields, and drinking water of concrete ionic composition and mineralization degree that decreases activity of all enzymatic systems of gastro-intestinal tract, hepatic among them.

EFFECT: higher efficiency of therapy.

2 ex, 3 tbl

 

The invention relates to medicine, namely to children's balneotherapy. Closest to the claimed is a well-known application of sulfide baths in combination with drinking sulfide water source No. 16, where the concentration of hydrogen sulfide exactly 10 mg/l (Jn. letter to help practitioners resorts, Pyatigorsk, 1990). These studies concerned the rehabilitation of patients after viral hepatitis A. Our research has shown that a combined application of the sulfide bath and sulfide water for drinking is not shown to children with hug even in the phase of minimal activity. In sulfide baths, where the hydrogen sulfide content is minimal, the hydrogen sulfide is rapidly destroyed and therefore harmful effects on the liver does not have. The use of sulfide water inside children with hug causes the activity of enzyme systems of the gastrointestinal tract, including the liver, in children, increased alkaline phosphatase, ACT, ALT. The essence of the invention lies in the fact that children with hug assigned sulfide baths with a minimum content of hydrogen sulfide and Slavophile chloride-hydrocarbonate-sodium-calcium water East. No. 24, warm (Pyatigorsk Seltzer). It is known that when applied externally sulfide water have on the human body multilateral action. When bathing in mineral water comes in contact with the skin, with extensive receptor field, across the irritation which the external environment is passed to the corresponding nerve centers. In addition, the ingredients of mineral water through the skin and the respiratory tract penetrate into the internal environment of the body and cause irritation interoreceptors internal organs. Chemical and thermal factors determine the response of the organism to these stimuli.

Our proposed method is carried out as follows: the intake of mineral water Slavophiles chloride-hydrocarbonate sodium-calcium low salinity - 4.5 g/l (Pyatigorsk East. No. 24), diet, physical therapy. The child accepts the sulfide bath (Pirogovskaya with hydrogen sulfide content of 10 mg/l).

In the last decade, chronic viral hepatitis deserves the most careful attention, as it causes incapacitation. Data from the scientific literature in recent years claim that viral hepatitis b, C, D, sick 1/3 of the globe, and therefore the urgency of the problem came in 1st place, ahead of AIDS. Every year from hepatitis kills about 1 million people.

Treatment with interferons allows to achieve a temporary remission in 30-40% of patients, combined treatment with lamivudine and rib prolongs remission in 60% of patients. The treatment is extremely expensive and inaccessible for the majority of the population. In this regard our study are quite significant.

The method is illustrated by the following examples.

N is the appropriate 1. With s Magomed 15 years, history 213/815 do in the clinic 29.01.2003, were discharged 27.02.2003, Complaints upon receipt of pain in the right hypochondrium before eating, nausea, constipation, loss of appetite, fatigue. Sick from 7 years of age, was treated in hospital, had been diagnosed with the disease Hungary. For the first time was tested for markers of hepatitis detected carrier of viral hepatitis b+D, received symptomatic therapy. In 2002, was treated at children's sanatorium in Yessentuki with a positive result. Early analysis without features. Admission: General condition average, expressed in the symptoms of chronic intoxication, pale, iparioli the hard palate and sclera, skin visible traces of scratches. Tongue coated dirty-white bloom. The abdomen is soft, painful in the right hypochondrium, so Kera. The liver acts of the rib for 3 cm, painful. Visually the thyroid gland is increased to the I-II century From other organs and systems no visible pathology.

Ultrasound 18/II-2003 - liver enlarged 142-51 mm, mosaic.

Eographically the study of the liver before and after treatment without the dynamics of the blood vessels reduced vascular tone right elevated ECG without pathology.

Prothrombin time before treatment 87,9% after 78%. Total bilirubin 23,0 m/l, ALT 0,218 mccam/l, ACT 0,112 mccam/l thymol test 4,8, total bilirubin after treatment 16,1, ALT 0,299, ACT 0,124, t is Malova sample of 3.7.

Alkaline phosphatase before treatment 209,9 u/l after - 1032 u/l, total protein before treatment 60 g/l after treatment - to 63.8 g/l, albumin, respectively 61,2% - 59.3 per cent.

Diagnosis: chronic viral hepatitis b+D, the minimum level of activity, eateries I class.

In the clinic the child received nutritional therapy (table No. 5), sulfide water sulphate-hydrocarbonate calcium-sodium mineral water (salinity of 4.5 g/l sulfide - 10 mg/l), Pyatigorsk source No. 16, exercise therapy, therapeutic tyubazhi during the month 2 times per week and basic therapy - sulfide baths (Pirogovskaya), t=37°C, duration 15 minutes, every day, on course No. 8.

After the treatment has improved the overall health of the child, improved appetite, increased emotional tone, no pain in the abdomen, nausea, normalized stool, however, objective clinical data has not changed: the liver remained the same size, has not changed the ultrasound results and gametogony. Decreased prothrombin time with 87,9%to 78%; ALT increased from 0,218 to 0,799, ACT with 0,112 to 0,124, Alp with 209,9 to 1032 E/L.

Decreased total bilirubin, thymol test.

Thus, the known method is not prescribed to children suffering hug even with minimal activity, not shown inside sulfide water, therefore we used another method - sulfide baths and inside slabo legisla chloride-hydrocarbonate-sodium-potassium mineral water East. No. 24 (mineralization 4.5 g/l).

Observation 2. S-VA Zalina 7 years, the case history No. 1545/14. Was admitted to the hospital on August 3, 2003 with complaints of pain in the abdomen, reduction of appetite, retarded physical development. The infant was often sick with various diseases, about which he conducted many infusions. The mother believes her sick with hepatitis 2 years, when he was diagnosed with an enlarged liver.

From history: was born at term with a weight of 3200 B.C. year of psychophysical development is age appropriate.

The disease: frequent colds, laryngotracheitis, 2 broken limbs. Brother hepatitis "B".

Admission: General condition is satisfactory, the right physique, low power. Pale skin, under-eye shadows, behind in growth. The lungs and heart without features, tongue coated dirty-white bloom. The abdomen is soft, painless in the right hypochondrium. The liver is under Ribera 3 see, dense. Emotionally labile.

Clinical indicators: ultrasound from 08.08.2003, liver 8E 124 mm, SS - 31 mm, echostructure fine, gall bladder 52×19 mm; wall up to 4 mm, the precipitate is a small number. Mud is not increased. Conclusion: echoprint hepatitis, GIT on hyponatremia type.

REG liver from 20.08 - blood pressure is reduced, to the right. increased venous outflow difficult is Yong.

ECG from 12.08. - marked sinus arrhythmia, violation of repolarization in paradisevalley area.

ALT 0,283 IADS member/l, ACT 0,226 IADS member/l, sublimate sample 96%, thymol 0.7 services. units, serum cholinesterase 0.78 services. units, gamma - GTP 0,6 IADS member/l; alkaline phosphatase - 495,2 u/l, cholesterol 4.26 deaths mmol/l, total protein 69%, G - 54,1, α1 globulin of 5.4%, α2-globulin 10,8%,-globulins of 12.6%, G-globulins of 17.1%.

PAG-0, creatore, amenorea, steatorrhea, acidic diarrhea.

Revealed a flat curve with a load of lactose (3,61; 4,53; 4,46)

In General, the analysis of blood and urine pathology no. After treatment has changed clinical indicators: decreased liver size up to 1.5 cm, REG disappeared venous congestion, ECG is unchanged, decreased ALT with 0,283 to 0,126 IADS member/l, ACT with 0,226 to 0,146 IADS member/l, alkaline phosphatase with 495,2 u/l up to 437 u/l, increased albumin with 54.1 per cent to 56.6%, increased the activity of trypsin in Calais from 0 to 1:40 (breeding), disappeared creatore, steatorrhea, amylacea.

She was discharged after 30 days with the improvement of the General condition of vanished abdominal pain, appetite improved, gone are the symptoms of chronic intoxication became more emotional, active. The liver decreased from +3.0 to +1.5 cm In a REG disappeared venous congestion, gone are the symptoms of cytolysis, cholestasis, mesenchymal inflammation, improved the function of the pancreas (increased activity of trypsin at Calais). Digestion - gone is ruatoria, amylacea, steatorrhea.

Thus, a single treatment in the clinic with the use of sulfide bathing and drinking Slavophiles chloride-hydrocarbonate-sodium-calcium water in the background diet contributed to the improvement of General condition, clinical and paraclinical parameters.

Thus, the proposed method, i.e. sulfide baths and Slavophile water, have an advantage over the previously described method and oprobirovanii us in children with hug. This gives us reason to believe that patients hug, in the phase of clinical and laboratory remission can be rehabilitated at the resort, revealed the advantage of the proposed method before known. The feature of the proposed method is that sulfur contained in the bath, could be a supporting factor for the liver, in the first minute breaks, and carbonated mineral water practically does not contain sulfur, as shown in the examples (see table 1-3).

Table 1
Clinical characteristics of groups
SignThe known method n=24%The proposed method for n=10%
FloorD19 (80%)7(70%)
M5(20%)3(30%)
Disease duration5 years10(40%)5(50%)
over 7 years14(60%)5(50%)
The degree of activityInactive2(8,3%)1(10%)
Minimum (I century)22(91,7%)9(90%)
Table 2
Dynamics of clinical indicators
Signs of illnessKnown

method n=24 (points)
Offer

Method n=10
D/lP/lPD/l P/lP
Appetite2,0±0,730,6±0,04<0,054,0±0,41,6±0,3=0,001
Abdominal pain2,29±0,20,45±0,5=0,0011,66±0,40,6±0,02=0,02
Heartburn0,33±0,010,04±0,003=0,001---
Nausea0,87±0,170,5±0,003=0,02---
Symptoms of XP. intoxication6,0±0,053,0±0,010,056,5±0,052,5±0,01<0,001
Coated tongue2,95±0,90,29±0,009=0,010,35±0,030,01±0,001<0,001
HC. liver 1,58±0,061,13±0,05>0,5was 2.76±0,471,25±0,25=0,02

Table 3
Dynamics laboratory parameters of children, the sick hug, in the course of treatment.
IndexThe known method n=24The proposed method for n=10
D/lP/lPD/lP/lP
The cytolysisALT0,25+0,030,23+0,03>0,050,160+0,110,11+0,03<0,5
ACT0,18+0,010,17+0,01>0,50,161+0,020,136+0,005<0,2
Maseng. FOTS.NV118,95+5,56105,54+9,9>0,050,14,5+0,7to 126.8+6,9<0,05
Erythrocyte sedimentation rateof 5.83+0,074,08+5,5>0,05---
Thymol test4,51+0,73,7+0,6=0,1 2,62+0,98to 2.06+0,9=0,5
CholestasisSelf300,8+42,8461,8+93,6<0,05411,98+38,4301+0,15=0,1
Ave. beat.2,08+0,91,23+0,5=0,11,24-0,081,1+0,5=0,5
β-lipop.1,09+0,21,11+0,09=0,53,0+0,223,6+0,1=0,02
Postal.2,11+0,162,23+0,09=0,5
γ-GTP0,31+0,040,37+0,63=0,5---
Hepatomas. syndromePETIT03,3+7,756,9+of 8.47>0,0587,4+2,991,0+0,83=0,01
Obilic.17,95+1,414,53+1,7=0,117,8+9,0720,1+0,5>0,5
The cholesterol.4,49+0,243,75+0,48=0,2---
Albumin54,2+2,449,64+3,9=0,555,9+1,1456,5+0,56 =0,5
D/l before the treatment
P/l after treatment
R - reliability of differences
All groups randomination

Treatment of children with chronic viral hepatitis, sulfide baths and mineral water, characterized in that the mineral water children take warm libopenal chloride-gidrokarbonatno sodium-calcium water of low salinity 100-200 g depending on the age within 30 days.



 

Same patents:

FIELD: medicine, abdominal surgery.

SUBSTANCE: one should drain biliary ducts and wash with 0.02%-sodium hypochlorite solution at the dosage of 150-200 ml, by drops, 3-4 times daily for 7-17 d. Moreover, also, during 7-17 d it is necessary to carry out infusion therapy through catheterized portal vein by applying conventional medicinal preparations and introduce 0.04%-sodium hypochlorite per 50-80 ml thrice daily. The innovation provides therapeutic efficiency at applying sodium hypochlorite in lower concentration against well known for sanitation of biliary tract that enables to decrease toxic effect of sodium hypochlorite during therapy conducted.

EFFECT: higher efficiency of therapy.

3 ex, 1 tbl

FIELD: pharmaceutical chemistry.

SUBSTANCE: invention deals with creating pharmaceutical compositions containing bile acids and methods of treatment using these compositions. For this purpose, invention provides transparent aqueous solution containing bile acid or its compounds, polysaccharide, and water. Amounts of the two formers are selected so that they remain in solution at all values within selected pH range. Administration of such a composition increases level of enterohepatic bile acid in body, including blood, and also increases absorption of bile acid. Addition of various drug to composition allows effective treatment of corresponding diseases.

EFFECT: improved transportation to body tissues of bile acids both as individual therapeutic agents and as drug forms.

47 cl, 11 dwg, 16 tbl, 18 ex

FIELD: medicine.

SUBSTANCE: method involves administering Corbiculin at a dose of 2 g three times a day when prediluted with 50 ml of water. The treatment course is 21 days long or longer until alanine aminotransferase and aspartate aminotransferase indices assume normal values.

EFFECT: enhanced effectiveness in normalizing hyperenzymemia and relieving clinic manifestations of cytolytic syndrome.

2 tbl

FIELD: medicine, hepatology.

SUBSTANCE: the present innovation deals with treating hepatitis and hepatic cirrhosis of different etiology. For this purpose, in case of viral hepatitis B and C at the stage of active viral replication one should inject sodium hypochlorite solution into central vein at concentration of 300-600 mg/l at the rate of 60 drops/min, per about 200-400 ml every other day, about 5-7 procedures/course; in case of viral hepatitis B and C beyond the stage of active viral replication one should inject sodium hypochlorite solution into peripheral vein at concentration of 300 mg/l at the rate of 30 drops/min per about 200-400 ml every other day, about 5-7 procedures/course; in case of hepatitis of non-viral etiology one should inject sodium hypochlorite solution into peripheral vein at concentration of about 200-300 mg/l at the rate of 30 drops/min, per about 200-400 ml daily, about 3-5 procedures/course; in case of hepatic cirrhosis it is necessary to inject sodium hypochlorite solution into peripheral vein at concentration of about 100-200 mg/l at the rate of 40 drops/min, per about 200-400 ml every other day, about 3-5 procedures/course. The innovation suggested provides increased efficiency of detoxication and anti-viral impact due to differentiated matching both the dosages and modes of preparation injection at different forms of hepatic lesions.

EFFECT: higher efficiency of therapy.

2 ex, 1 tbl

FIELD: medicine, gastroenterology, phytotherapy.

SUBSTANCE: invention relates to the development of agent used in treatment of stomach and duodenum ulcer disease with eradication of microorganism Helicobacter pylori occurring on the background of liver chronic diseases. Agent represents a species of medicinal plants and comprises common milfoil, fenestrate Saint-John's-wort, medicinal matricary, sweet flag rhizome with roots, common wormwood, sandy immortelle, black elder flowers, medicinal pot-marigold, peppermint, sage, dioecious nettle, umbellate centaury, medicinal sweet clove, medicinal dandelion roots, great burnet rhizomes, gum-tree leaves, tansy, maize stigmas, creeping thyme, cowberry leaves, flax seeds, tormentil rhizomes, linden flowers, common bear berry taken in the therapeutic dosage and in the definite mass ratio of components. The agent reduces the toxic effect of hepatobiliary system and prolongs the remission periods.

EFFECT: improved, enhanced and valuable medicinal properties of agent.

2 tbl, 4 ex

FIELD: medicine, pharmaceutical industry, phytotherapy.

SUBSTANCE: invention proposes an agent used in treatment of infectious diseases. Agent used in treatment of infectious diseases comprises chitosan of polyfraction composition with amine groups of molecular mass from monomeric link - glucosamine to ˜350 kDa and deacetylation degree from ˜68 to ≤ 95% and vegetable raw aqueous extract chosen from the following group: Cetraria thallus, sage official herb, cocklebur leaves, black poplar buds, common wormwood herb, red roots, burdock roots, French honey-suckle herb, bur-marigold tripartite herb, sandy common immortelle flowers, dropwort elm-leaved flowers, river avens (Geum) roots, licorice glabrous roots, swampy sweet flag roots, burnet official roots,, nettle dioecious herb, swampy cudweed herb, common milfoil herb, sweet clover official herb, gum-free leaves, dropwort, willow bark, birch leaves, bilberry leaves, willow-herb narrow-leaves herb, peppermint herb, fenestrate Saint-John's-wort herb, knot-grass herb, shepherd's purse herb, violet pensy tricolor herb, speedwell herb, pot-marigold flowers, common tansy flowers, matricary official flowers, chicory roots, dandelion official roots, tormentil roots, cinnamon wild rose fruits, viburnum leaves, pinnate kalanchoe and maize stigmas. Aqueous extract is prepared by extraction of vegetable raw with demineralized water under definite conditions. Agent promotes to effective treatment of infectious diseases, such as chlamydiosis, herpes, erysipelas, viral hepatitis A and B, gastroenteric tract diseases, acute enteric infectious, and to declining period of clinical symptoms of diseases said.

EFFECT: valuable medicinal properties of agent.

10 cl, 2 dwg, 12 ex

FIELD: medicine, hepatology, chemical-pharmaceutical industry, biotechnology.

SUBSTANCE: invention relates to a biotransplant used in treatment of chronic hepatitis and liver cirrhosis and comprising mesenchymal stem cells obtained from fetal or donor material. The parent tissue is subjected for disaggregation followed by culturing as fixed colonies in the growth medium containing fetal calve serum and glutamine and passage at low density value with change of medium composition and cultivation is carried out without accumulation cells with mature stroma in culture. Also, invention relates to a method for treatment of chronic hepatitis and liver cirrhosis that involves administration of indicated biotransplants by using venous catheter or by puncture in the portal system veins, or by using arterial catheter in splenic artery, or by puncture in spleen parenchyma, or by intraperitoneal route, or by puncture in gastrocolic omentum. Invention provides enhancing effectiveness in complex effect on damaged liver.

EFFECT: improved preparing method, improved treatment method.

13 cl

FIELD: medicine, oncology, biology.

SUBSTANCE: method involves per os administration of the preparation "oligokhit activ" to a cancer carrier in the dose 20-24 mg/kg of weight for 7 days, not less. Method provides elimination of dystrophic changes in hepatocytes caused by metabolic disturbances in body of a cancer carrier, to improve proliferative activity of hepatocytes and to recover microcirculation.

EFFECT: improved correction method.

1 tbl, 1 ex

FIELD: medicine, hepatology.

SUBSTANCE: invention relates to treatment of chronic hepatitis C. Method involves administration in a patient α2A-interferon modified with polyethylene glycol (PEG)(conjugate PEG-IFN-α2A) in combination with ribavirin. Method provides the prolonged clearance of virus that promotes both activity with respect to cells proliferation and effective treatment of disease.

EFFECT: enhanced effectiveness of preparation.

2 cl, 1 tbl, 1 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to derivative of triazaspiro[5.5]undecane of the formula (I): wherein R1 means compound of the formula (1): or (2): wherein G represents a bond, (C1-C4)-alkylene, (C2-C4)-alkenylene or -CO-; ring A represents: (1) C5-10-membered mono- or bicarbocyclic ring or (2) 5-10-membered mono- or bicyclic heterocycle comprising 1-2 nitrogen atoms and/or 1-2 oxygen atoms; substitute R6 means the following values: (1) (C1-C4)-alkyl, (2) halogen atom, (3) nitrile group, (4) trifluoromethyl group and others; R2 represents: (1) (C1-C4)-alkyl, (2) (C2-C4)alkynyl or (3) (C1-C4)-alkyl substituted with a substitute represented in claim 1 of the invention claim; each R3 and R4 represents independently: (1) hydrogen atom, (2) (C1-C4)-alkyl or (3) (C1-C4)-alkyl substituted with 1-2 substituted taken among: (a) Cyc 2 and (b) hydroxy-group (wherein Cyc 2 represents (1) C5-6-membered monocarbocyclic ring or (2) 5-6-membered monocyclic heterocycle comprising 1-2 nitrogen atoms and/or one oxygen atom), or R3 and R4 form in common group of the formula: wherein R26 represents (C1-C4)-alkyl or Cyc 2; R5 represents hydrogen atom or (C1-C4)-alkyl, its quaternary ammonium salt, its N-oxide or its nontoxic salt. Also, invention relates to pharmaceutical composition inhibiting HIV, regulator of chemokine/chemokine receptor and agent used in treatment and prophylaxis of some diseases, such as inflammatory diseases, asthma, atopic dermatitis, nettle rash, allergic diseases, nephritis, hepatitis, arthritis and other diseases that comprise as an active component above described compound of the formula (I) or its quaternary ammonium salt, its N-oxide or its nontoxic salt. Also, invention relates to (3R)-1-butyl-2,5-dioxo-3-((1R)-1-hydroxy-1-cyclohexylmethyl)-9-(4-(4-carboxyphenyloxy)phenylmethyl)-1,4,9-triazaspiro[5.5]undecane or its pharmaceutically acceptable salt and pharmaceutical composition based on thereof, and to (3R)-1-butyl-2,5-dioxo-3-((1R)-1-hydroxy-1-cyclohexylmethyl)-9-(4-(4-carboxyphenyloxy)phenylmethyl)-1,4,9-triazaspiro[5.5]undecane hydrochloride and pharmaceutical composition based on thereof.

EFFECT: valuable medicinal properties of derivative and composition.

16 cl, 32 ex

FIELD: medicine, physiotherapy, balneotherapy.

SUBSTANCE: one should prescribe a curative complex including calcium pantothenate per 0.1 g thrice daily and balneotherapy with carbonate low-mineralized hydrocarbonate magnesium-sodium-calcium-iron water for inner intake per 200 ml thrice daily 30 min before meals, during 3 wk. The present innovation enables to normalize respiratory ventilation capacity and decrease renal risk due to normalizing phosphorus-calcium exchange and higher content of renewed glutathione that is provided due to synergistic action of calcium pantothenate and mineral water.

EFFECT: higher efficiency of therapy.

1 cl, 1 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: method involves giving mineral water without gas at 18°C temperature in the amount of 200 ml in one dose during 18 days. Water like Konstaninowskaya-1 is administered in the morning and evening time 20 min before taking meals and when going to bed.

EFFECT: enhanced effectiveness of kidney disease treatment.

2 tbl

FIELD: medicine, stomatology.

SUBSTANCE: invention relates to a method for prophylaxis of caries. Method involves every day mouth cavity gargling with natural mineral water with the fluoride content above 1.2 mg/ml during teeth cleansing and after cleansing for 1 min, not less, by course for 7-10 days. In partial case method involves using natural mineral water "Svetloyarskaya" with the fluoride content 1.7 mg/l for prophylaxis of caries in children living in regions with reduced fluoride content in drinking water. Method provides effective prophylaxis of caries excluding toxic effect of trace elements on body presenting in mineral water.

EFFECT: enhanced effectiveness of prophylaxis.

3 cl, 3 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: method involves sequentially administering ultrasonic inhalations with sodium hydrocarbonate alkaline mineralized and boric mineral water with increased fluorine concentration at aerosol flow speed being equal to 5 l/min during 3 min with following olive oil or other kernel oil inhalation. Then laser radiation therapy is applied to skin above left cubital vein with pulse frequency of 80 Hz and C YII-Th IY reflexogenic segmental zones are treated next to it during 5 min on the left dorsal side at pulse succession frequency being equal to 3000 Hz, pulse power of 2 W alternating it every other day with balneological hydrogen sulfide treatments given to boys at hydrogen sulfide concentration of 50-100 mg/l and to girls at hydrogen sulfide concentration of 25-50 mg/l. The total treatment course is 8 balneological treatments and 10 physiotherapy procedures long.

EFFECT: improved adaptive organism capabilities and its tolerance to physical loads.

3 tbl

FIELD: medicine, physiotherapy.

SUBSTANCE: one should prescribe the diet #1, morning exercises, total pearl baths, intake of mineral sulfate-chloride-sodium-magnesium water, manual massage and peloid applications onto area of wide girdle. The impact mentioned should be fulfilled daily at the quantity of 10 procedures. The intake of mineral water mentioned at 6 g/l mineralization should be prescribed thrice daily per 100-150 ml 30 min before meals. Additionally, one should prescribe phytospecies consisting of the following grasses: everlasting, St. John's wort, yarrow, common horsetail and peppermint at the ratio of 3:3:2:2:2, correspondingly per 50 ml thrice daily after meals for 12-14 d. The innovation enables to improve the values of motor-evacuatory function of bile-excretory system, improve biochemical composition of bile, parameters of regional hemodynamics, and, also, improve morphological state of gastric and duodenal mucosa and restore the continuity of mucosal layer.

EFFECT: higher efficiency of therapy.

1 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: method involves applying dietary treatment, balneotherapy with carbonic acid low mineral content hydrocarbonate-magnesium-sodium-calcium-chalybeate water being administered at a dose of 200 ml 3 times a day 30 min before taking meals and biologically active nutrient additive like Capilar in eating at a dose of 0.25 g 3 times a day during 21 days.

EFFECT: enhanced effectiveness in adjusting acid-base state, immune disorders, magnesium-calcium and calcium-phosphorus metabolism.

2 cl, 2 tbl

FIELD: medicine, therapy, gastroenterology.

SUBSTANCE: method involves preliminary assay of the disorder type in gallbladder motor contraction and bile-excretion ways followed by prescribing thermal low-mineralized hydrocarbonate-sodium-sulfate-calcium-magnesium mineral water in the dose by 200-300 ml, 3 times per a day, 1 h before eating, tubages № 3 with mineral water, bathes and shower with mineral water every day for 10-14 days. In the hypotonic type of motor activity method involves mineral water at temperature 25-30°C, and in the hypertonic type - at temperature 38-40°C. Method provides accelerating in scars formation of ulcers and epithelization of erosions in gastroduodenal system, to prevent frequent exacerbations and to reduce activity of Chelicobacter-induced inflammation.

EFFECT: improved therapy method.

4 tbl, 2 ex

FIELD: medicine, gastroenterology.

SUBSTANCE: method involves preliminary assay of type in motor system activity injury of gallbladder contraction and cholagogic ways and then thermal low-mineralized hydrocarbonate-sodium-sulfate-calcium-magnesium mineral water is prescribed in the dose 200-300 ml, 3 times per a day, 1 h before eating, tubage № 3 with mineral water, baths and shower bath with mineral water every day for 10-14 days. In the hypomotoric type method involves using water with temperature 25-30°C and in the hypermotoric type - at temperature 38-40°C. Method provides arresting the pain syndrome, to diminish asthenic-depressive syndrome and to reduce the "sludge"-syndrome.

EFFECT: improved and valuable treating method.

2 ex

FIELD: physiotherapy and health resort treatment.

SUBSTANCE: method envisages drinking mineral water, performing intragastric electrophoresis with mineral water, magnet-laser therapy, massage, and baths. Additionally, 2-3 days before physiotherapy and during physiotherapy, biologically active additive "succinic acid" is administered in daily dose 3 x 0.5 g after meal. Intragastric and magnet-laser therapy are performed every day consecutively without interval between them. Treatment course consists of 8-10 procedures. Method allows achieving stable remission in case of indicated diseases thanks to integrated positive effect produced on inflammatory process, velocity of epithelization of ulcerous and erosive defects, acid-forming, neutralizing, and motor functions in gastroduodenal region on the whole.

EFFECT: enhanced treatment efficiency.

5 tbl, 2 ex

FIELD: urological physiotherapy and balneology.

SUBSTANCE: in addition to mineral bathes, patient is alternately subjected to physiotherapy in the form of renal tubage consisting of paraffin applications at 60-65°C and drinking low-mineralized hydrocarbonate-calcium neutral water preheated to 38-40°C in total dose 200 ml in each session. Drinking of water is started 18-20 min after use of applications.

EFFECT: prolonged stable remission and achieved normal rheology of blood in damaged kidney.

7 ex

FIELD: medical engineering.

SUBSTANCE: device has patient cabinet, manufactured as air- and water-proof casing from wood of coniferous trees and having door and opening for introducing patient head. The opening is covered with flexible envelope. The device also has heating elements combined with vapor generator having fan and vapor-producing reservoir connected to active medium supply unit with tubes having injectors mounted in the casing and unit for supplying medical mixture. Temperature pickup is mounted on internal casing wall surface connected to programmed control unit, having heating elements, fan, compressor, unit for supplying drug mixture having injection control unit and control desk having emergency unit, control buttons and indication panel. Heating elements, vapor production device and compressor are mounted under casing floor in waterproof tray.

EFFECT: automated sauna control; high safety in operation.

12 cl, 3 dwg

Up!